Inventor
LOW JONATHAN D
US22 patents
⚠️ This page may combine multiple inventors who share the name “LOW JONATHAN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
21 patentsUS10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
US11306087B2Apr 19, 2022
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC16 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US9611261B2Apr 4, 2017
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC25 citations94
US9085576B2Jul 21, 2015
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC31 citations94
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11993597B2May 28, 2024
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC8 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US10632128B2Apr 28, 2020
Compounds that inhibit Mcl-1 protein
AMGEN INC5 citations83
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9012446B2Apr 21, 2015
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
AMGEN INC4 citations72
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US9296734B2Mar 29, 2016
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC2 citations62
US11224601B1Jan 18, 2022
Compounds that inhibits MCL-1 protein
AMGEN INC0 citations61
US11279712B2Mar 22, 2022
Macrocyclic compounds that inhibit MCL-1 protein
AMGEN INC0 citations51
US10821115B2Nov 3, 2020
Compounds that inhibit Mcl-1 protein
AMGEN INC0 citations51
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US10889581B2Jan 12, 2021
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
AMGEN INC0 citations47
US12473289B2Nov 18, 2025
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
AMGEN INC0 citations46